|
 |
RepaglinideThis page contains recent news articles, when available, and an overview of Repaglinide but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.Overview: Repaglinide (when available) Repaglinide is an oral blood glucose-lowering drug of the meglitinide class used in the management of type 2 diabetes mellitus (also known as non-insulin dependent diabetes mellitus or NIDDM). Repaglinide lowers blood glucose levels by stimulating the release of insulin from the pancreas. This action is dependent upon functioning beta cells in the pancreatic islets. Insulin release is glucose-dependent and diminishes at low glucose concentrations. For the treatment of Type II diabetes mellitus Mechanism Of Action: Repaglinide closes ATP-dependent potassium channels in the b-cell membrane by binding at characterizable sites. This potassium channel blockade depolarizes the b-cell, which leads to an opening of calcium channels. The resulting increased calcium influx induces insulin secretion. The ion channel mechanism is highly tissue selective with low affinity for heart and skeletal muscle. News Articles on Repaglinide Better weight control with metformin and insulin - Nov 11, 2009 However, weight gain was less with metformin plus insulin than with repaglinide plus insulin (difference in mean body weight between treatments –2.51 kg). ... Endochrinology Update FDA Safety Changes: DepoDur, Neoral, Lexiva - Nov 4, 2009 Cyclosporine may increase the plasma concentrations of repaglinide and thereby increase the risk for hypoglycemia, the FDA warned. Repaglinide appears to be ... Medscape Modern insulins drive up Novo Nordisk earnings - Oct 29, 2009 Human insulins slipped 2% to 2.48 billion kroner and oral antidiabetic products, notably NovoNorm/Prandin (repaglinide), were down 3% to 650 million kroner. ... Pharma Times Cyclosporine markedly raises the plasma concentrations of repaglinide... - May 27, 2005 Background and Objective: Repaglinide is an antidiabetic drug metabolized by ... At 9 AM on day 2, they ingested a single 0.25-mg dose of repaglinide. ... Nature.com Caraco Pharma gets tentative FDA nod for generic Prandin - Aug 13, 2007 The generic version, Repaglinide, is indicated to lower the blood glucose in patients with type 2 diabetes mellitus, whose high blood-sugar levels cannot be ... Reuters Sciele signs exclusive marketing agreement with Novo Nordisk; ups... - Nov 19, 2007 US to other Novo Nordisk (nyse: NVO - news - people ) products containing repaglinide,' which is the active ingredient in both Prandin and PrandiMet. ... Forbes Expanded EU diabetes drug application withdrawn - Oct 16, 2006 NovoNorm (repaglinide) and Prandin (repaglinide) have both received regulatory approval previously in the EU to be used in combination with exercise and ... Hays Pharma Telithromycin, but not montelukast, increases the plasma concentration... - Aug 4, 2005 Background and Objective: The antidiabetic repaglinide is metabolized by cytochrome P450 ... On day 3, they ingested a single 0.25-mg dose of repaglinide. ... Nature.com Cholestatic Hepatitis Associated With Repaglinide - Mar 16, 2005 Repaglinide is a fast, short-acting meglitinide analog antidiabetic drug approved for the treatment of type 2 diabetes. Hypoglycemia is a major adverse ... RedOrbit Learn about Repaglinide from Consumer Reports Health. - Jan 5, 2007 Repaglinide is used to treat type 2 diabetes (condition in which the body does not use insulin normally and, therefore, cannot control the amount of sugar ... consumerreports.org Novo Nordisk A/S - Regulatory Approval - Jun 24, 2008 It is the first fixed-dose combination of repaglinide, a fast-acting insulin secretagogue, and metformin, an insulin sensitiser. ... marketwire.com … With Type 2 Diabetes Achieve QoF HbA1c Targets With Repaglinide... - Aug 31, 2008 Repaglinide has a distinct mode of action that helps control HbA1c by ... An analysis of the repaglinide and metformin treatment from 2005/6 found that only ... Medical News Today - Medical News Today (press release) … Endogenous Insulin Production by Repaglinide Stimulation of C- … - Jun 14, 2005 C-peptide stimulation test a practical diagnostic method to determine the presence of endogenous insulin production, and eliminating guesswork about when ... Diabetes In Control … With Type 2 Diabetes Achieve QoF HbA1c Targets With Repaglinide... - Jul 20, 2008 Repaglinide has a distinct mode of action that helps control HbA1c by ... An analysis of the repaglinide and metformin treatment from 2005/6 found that only ... Medical News Today - Medical News Today (press release) FDA Approved Generic Prandin - Aug 15, 2007 FDA has granted tentative approval for Caraco Pharmaceutical Laboratories' Abbreviated New Drug Application (ANDA) for Repaglinide Tablets USP (repaglinide) ... emaxhealth.com Generic name: Repaglinide - Dec 1, 2005 Prandin is used to reduce blood sugar levels in people with type 2 diabetes (the kind that does not require insulin shots). It's prescribed when diet and ... Free with registration - PDR Family Guide to Prescription Drugs - AccessMyLibrary.com Diabetes Therapy; Researchers' findings advance diabetes therapy … - Feb 1, 2005 Study 2: The combination of repaglinide and metformin enhanced early- and ... Repaglinide increased early and late phases of insulin responses in HC, ... Pay-Per-View - Life Science Weekly - Factiva, from Dow Jones Diabetes Therapy; Findings advance knowledge in diabetes therapy … - Mar 7, 2006 Study 3: Repaglinide reduces oxidative stress in the tissues of diabetic rabbits. "In this study, the anti-oxidative properties of repaglinide were examined ... Pay-Per-View - Life Science Weekly - Factiva, from Dow Jones Diabetes Therapy; Researchers' findings advance diabetes therapy … - Feb 4, 2005 Study 2: The combination of repaglinide and metformin enhanced early- and ... Repaglinide increased early and late phases of insulin responses in HC, ... Pay-Per-View - Drug Week - Factiva, from Dow Jones Repaglinide, í?¡ìˆ˜ ì‹ ì†?…ì‹?후•공복시 ì €í˜ˆë‹¹ 발현 낮아 - Sep 29, 2007 KATP channelì?€ 뇌, 심장근육, 혈관í?‰í™œê·¼ì—?ë?„ 존재하는ë?° 뇌ì?˜ SUR 아단위는 췌장 ë² íƒ€ì„¸í?¬ì™€ ë?™ì?¼í•œ 반면(SUR-1), 심장근육ì?´ë‚˜ 혈관í?‰í™œê·¼ì?˜ SUR 아단위는 ê°?ê°? ... 디지틀보사 Press Release: Novo Nordisk Inc. Announces Exclusive Agreement With … - Nov 19, 2007 PrandiMet(R) is a combination tablet of repaglinide and metformin, which has yet to be ... Sciele will also market PrandiMet (repaglinide/metformin). ... Pay-Per-View - PR Newswire - HighBeam Research Inhibitory and Inductive Effects of Rifampin on the Pharmacokinetics... - Oct 4, 2006 It had previously been shown that rifampin reduced the exposure to repaglinide by 50% when repaglinide was simultaneously administered with rifampin, ... Nature.com Diabetes Diagnosis; Potential beta-cell imaging agent synthesized - Jan 1, 2005 ..."In vitro testing of the nonradioactive methoxy-repaglinide was performed to characterize the affinity for binding to the human SUR1 isoform," said Bjorn ... Pay-Per-View - Obesity, Fitness & Wellness Week - Factiva, from Dow Jones Older agents for type 2 diabetes equal or superior to newer agents... - Oct 1, 2007 Treatment with TZDs and treatment with repaglinide was associated with weight ... Treatment with second-generation sulfonylureas and with repaglinide was ... Free with registration - Formulary - AccessMyLibrary.com Understanding Hypoglycemia - Jul 25, 2006 Nateglinide and repaglinide are taken with meals and act for only a short time. The risk of hypoglycemia is lower than for sulfonylureas, but it is still ... Diabetes Self Management Emerging Evidence of the Impact of Kidney Disease on Drug Metabolism ... - Jan 7, 2008 For instance, the meglitinide hypoglycemic drug repaglinide undergoes hepatic ... 15 These data suggest that hepatic clearance of repaglinide, mediated by ... Nature.com Prandin Offers Advantages in Elderly Diabetics - Aug 15, 2006 ..."The major clinical implication of our study," said Dr. Francesco Purrello, "is that short-acting hypoglycemic drugs, such as repaglinide, should be used in ... Diabetes In Control Press Release: Caraco Pharmaceutical Laboratories, Ltd. Announces … - Aug 13, 2007 Repaglinide is indicated as an adjunct to diet and exercise to lower the blood ... We believe we have a first to file position on Repaglinide, which could ... Pay-Per-View - PR Newswire - HighBeam Research Article: Good glucose control.(DIABETES Update)(Brief Article) -... - Nov 1, 2005 ...of the American Diabetes Association June 23, 2001, showed repaglinide ... because they suggest blood glucose control can be improved with repaglinide . ... Pay-Per-View - Saturday Evening Post - HighBeam Research Analysis of diabetes drugs - Jul 17, 2007 Glimepiride, glipizide, glyburide, and repaglinide are associated with hypoglycemia (when blood glucose levels go too low) more than other diabetes drugs. ... News-Medical.net While Most Diabetes Drugs Provide Similar Glucose Control, Some Offer... - Jul 23, 2007 Glimepiride, glipizide, glyburide, and repaglinide are associated with hypoglycemia (when blood glucose levels go too low) more than other diabetes drugs. ... emaxhealth.com Article: Should PCOS be treated with insulin sensitizers or oral … - Feb 15, 2006 Article: Prandin(R) (Repaglinide) Approved for New Indication: Combination ... ... Repaglinide stimulates insulin release from the pancreas; ... Pay-Per-View - OB GYN News - HighBeam Research Most Diabetes Drugs Provide Similar Glucose Control - Jul 13, 2007 Glimepiride, glipizide, glyburide, and repaglinide are associated with hypoglycemia (when blood glucose levels go too low) more than other diabetes drugs. ... newswise.com Press Release: Liraglutide Phase 2 Study Shows Increased Insulin … - Jun 13, 2006 Article: Repaglinide Has Unique Mechanism Of Action.(Prandin stimulates ... Drug Week; July 27, 2001 ; 700+ words ... ... repaglinide stimulates insulin ... Pay-Per-View - PR Newswire - HighBeam Research Sciele Expects to Launch Six Products in 2008; Reaffirms Revenue and ... - Jan 9, 2008 Prandin[R] (repaglinide) for type II diabetes, and, upon FDA approval, PrandiMet[R] (repaglinide/metformin) also for type II diabetes; ... Free with registration - Business Wire - AccessMyLibrary.com Drug to help diabetics during Ramzan - Sep 20, 2005 According to the doctors, drugs like Repaglinide and Natiglinide, short acting ... Repaglinide and Natiglinide are short duration drugs that will help bring ... Times of India Clinical news: Combination regimen benefits in diabetes.(Brief... - Apr 14, 2007 A combination of repaglinide, metformin and bedtime neutral protamine hagedorn ... The group taking repaglinide, metformin and NPH insulin were on only 58.1 ... Free with registration - Chemist & Druggist - AccessMyLibrary.com Press Release: Metabolex Initiates Phase 2/3 Trial of Metaglidasen in... - Jun 10, 2006 Article: Prandin(R) (Repaglinide) Approved for New Indication: Combination ... ... Repaglinide stimulates insulin release from the pancreas; ... Pay-Per-View - PR Newswire - HighBeam Research Nordisk and Sciele sign marketing deal. - Nov 26, 2007 The agreement also transfers marketing rights to Nordisk's PrandiMet (repaglinide plus metformin), which is currently in development and is yet to be ... Free with registration - Pharma Marketletter - AccessMyLibrary.com Generic diabetes drugs - Sep 8, 2008 Neither repaglinide (Prandin) nor nateglinide (Starlix) (both of which spur the pancreas to release more insulin quickly after meals) has a generic form. ... Diabetes Self Management For Type 2 Diabetes, Older Drugs Seem Tried and True - Jul 16, 2007 ..."Sulfonylureas and repaglinide were associated with greater risk for hypoglycemia, thiazolidinediones with greater risk for heart failure, and metformin ... MedPage Today Article: 2 adult diabetes drugs appear safe in children.(Metabolic … - Aug 1, 2005 Article: Repaglinide (Prandin(R)) Shows Greater Improvement in Blood ... PR Newswire; June 26, 2003 ; 700+ words ... ... escalation with metformin (to 1000 ... Pay-Per-View - Family Practice News - HighBeam Research Company Profile Report - Oct 4, 2008 PrandiMet (Repaglinide/Metformin Fixed Combo) ... Prandin (Repaglinide). Intermediary Metabolism Disorders. Hypercholesterolemia ... $50.00 - Revere Reports - Revere Do sulfonylurea drugs increase the risk of cardiac events?( … - Jan 17, 2006 Of the meglitinides, it is unlikely that repaglinide, a benzoic acid derivative with a shorter period of attachment to the ATP-sensitive potassium channels, ... Free with registration - CMAJ: Canadian Medical Association... - AccessMyLibrary.com Press Release: Metabolex Announces Presentation of Metaglidasen … - Sep 8, 2005 Article: Prandin(R) (Repaglinide) Approved for New Indication: Combination ... ... Repaglinide stimulates insulin release from the pancreas; ... Pay-Per-View - PR Newswire - HighBeam Research Company Profile Report - Oct 4, 2008 MetPrandin (Repaglinide/Metformin Fixed Combo) ... Prandin (Repaglinide). Intermediary Metabolism Disorders. Hypercholesterolemia ... $50.00 - Revere - Alacra Store Healthcare Republic - Search results for Diabetes - Nov 30, 2006 Daiichi Sankyo has acquired the sales and marketing rights for repaglinide in the UK. Repaglinide w... Read more. Click on a filter below to refine your ... Healthcare Republic - Healthcare Republic Press Release: New Data From Head-to-Head Phase 3 Trial Demonstrate … - Oct 17, 2008 PRNewswire/ -- Novo Nordisk A/S (NYSE: NVO ... promote Prandin(TM) (repaglinide) and Novo Nordisk's full range of ... strategic needs. ... Pay-Per-View - PR Newswire - HighBeam Research {beta}-Cell Insulin Secretory Response to Oral Hypoglycemic Agents Is... - Mar 1, 2006 There was a marked decrease in the dextrose infusion rate with administration of either repaglinide or glipizide at hypoglycemia compared with drug ... Journal of Clinical Endocrinology and... Press Release: Schering-Plough Highlights PEGINTRON(TM) and … - Apr 17, 2008 PR Newswire; June 23, 2001 ; 700+ words ... ... repaglinide is effective in combination therapy.2,3 Repaglinide is currently approved for combination ... Pay-Per-View - PR Newswire - HighBeam Research Press Release: Metatarsalgia (or Forefoot Pain) Affects Millions of … - Apr 18, 2008 Article: Research Showing Prandin(R) (repaglinide) Tablet Improved ... ... Article: MULTINATIONAL STUDY SHOWS NOVONORM (REPAGLINIDE) IMPROVES ... ... Pay-Per-View - PR Newswire - HighBeam Research Kinetics-Effect Relations of Insulin-Releasing Drugs in Patients With... - Jan 23, 2005 This fostered development of meglitinide analogs, such as nateglinide and repaglinide, which are clinically effective insulin-releasing drugs. ... RedOrbit Loislaw Federal District Court Opinions - NOVO NORDISK v. CARACO … - Sep 20, 2006 The claims in the `358 patent require the drug repaglinide, which is marketed by Plaintiffs. Defendant Caraco is a Michigan corporation that filed an ... Pay-Per-View - Loislaw Federal District Court Opinions - Loislaw Prescribing for Diabetes - Oct 8, 2005 For some patients, the insulin secretagogues nateglinide and repaglinide may be required. If there is intolerance to all of these, there may be a place for ... RedOrbit Pharmacy update - Drugs used in type 2 diabetes. - Feb 24, 2007 At the time of writing, repaglinide and nateglinide are licensed for use as combination therapy with metformin, and repaglinide is also licensed for use as ... Free with registration - Chemist & Druggist - AccessMyLibrary.com Novo: Øget dødelighed hos intensivt behandlede diabetikere - Jun 26, 2008 Novo Nordisks to diabetestabletter Prandin og Prandimet indeholder ikke glitazoner, men derimod repaglinide (Prandin) og repaglinide blandet med metformin ... UgensErhverv Older type 2 drugs are as effective as newer ones.(Metabolic Disorders... - Sep 15, 2007 Weight gains ranging from 1 to 5 kg were seen with most other oral diabetes medications: thiazolidinediones, repaglinide, and second-generation ... Pay-Per-View - Family Practice News - HighBeam Research Diabete di tipo 2: le sulfoniluree aumentano il rischio di eventi... - Apr 4, 2006 Tra le meglitinidi, è improbabile che la Repaglinide, un derivato ... Quando la Repaglinide è stata confrontata con la Gliburide durante gli studi clinici ... XagenaSalute 알파글루코시ë?°ì?´ì¦ˆ, ì‹?후 혈당 완만 ì–µì œ - May 4, 2006 ...êµë‚´ì—?ì„œ 사용 가능한 약물로는 Repaglinide와 Nateglinideê°€ 있다<í‘œ 2>. â–³ Repaglinide(Prandin, Novonorm) = ë² íƒ€ì„¸í?¬ì?˜ ATP - ì?˜ì¡´ì„± 칼륨 통로ì—?ì„œ 설í?°ìš”ì†Œì œì™€ ... bosa.co.kr ì?¸ìŠ?ë¦°ë¶„ë¹„ì´‰ì§„ì œì?˜ 새로운 ê³ ì°° - Nov 3, 2005 ...그러나 glibenclamide, glimepiride, meglitinide, repaglinideì?˜ 경우ì—?는 ... Repaglinide는 benzamido moiety만 ê°–ê³ ìžˆìœ¼ë‚˜ 소수성ì?´ 매우 ê°•í•´ 1ê³³ì—?서만 ê²°í•© ... 메디칼트리뷴 Danish shares close slightly lower, Carlsberg higher UPDATE - Aug 14, 2007 US based Caraco Pharmaceutical Laboratories said it has gained tentative FDA approval for repaglinide, a generic version of the Danish group's diabetes ... Forbes Article: Gastric bypass reduces [HbA.sub.1c] levels in diabetes.(News)... - Aug 1, 2008 Article: Focus on repaglinide: An oral hypoglycemic agent ... ... Repaglinide (Prandin, Novo Nordisk Pharmaceuticals, Inc), the most recently FDA-approved ... Pay-Per-View - Internal Medicine News - HighBeam Research Confronto fra i vari farmaci antidiabetici - Jul 18, 2007 I glitazoni, la metformina e la repaglinide portano ad un controllo glicemico paragonabile a quello ottenuto con le sulfoniluree di seconda generazione: con ... Pillole.org Older Diabetes Drug Sometimes the Best Choice - Jul 16, 2007 Another drug, repaglinide, was linked to less-serious forms of hypoglycemia in the elderly and people who skip meals. Slutsky said the newer drugs are ... Washington Post Danish shares flat midmorning, William Demant higher - Aug 14, 2007 US-based Caraco Pharmaceutical Laboratories said it has gained tentative FDA approval for repaglinide, a generic version of the Danish group's diabetes ... Forbes Article: Gastric bypass lowers Hb[A.sub.1c] levels in type 2.(Metaboli... - Aug 15, 2008 Article: Focus on repaglinide: An oral hypoglycemic agent ... ... Repaglinide (Prandin, Novo Nordisk Pharmaceuticals, Inc), the most recently FDA-approved ... Pay-Per-View - Family Practice News - HighBeam Research In the News; Heart failure risk prompts warning labels on diabetes... - Aug 1, 2007 Drugs in this class include nateglinide (Starlix) and repaglinide (Prandin). Slows the absorption of glucose by blocking enzymes that break it down in the ... Free with registration - Harvard Women's Health Watch - AccessMyLibrary.com Press Release: Metabolex's Investigational Treatment for Type 2... - Mar 22, 2005 PR Newswire; June 23, 2001 ; 700+ words ... ... repaglinide in combination ... Article: Prandin(R) (Repaglinide) Approved for New Indication: Combination . ... Pay-Per-View - PR Newswire - HighBeam Research Severe iatrogenic hypoglycemia in type 2 diabetes mellitus - Mar 2, 2006 Hypoglycemia occurs in patients with T2DM treated with insulin or with an insulin secretagogue, such as a sulfonylurea, repaglinide or nateglinide. ... Nature.com A case of recurrent gastrointestinal bleeding and protein-losing … - Sep 21, 2006 ...omeprazole (40 mg daily), digoxin (0.1 mg daily), and repaglinide (0.5 mg three times a day before meals) for his type 2 diabetes. ... Nature.com Newer drugs queried for type 2 diabetes - Jul 25, 2007 While they found little difference in glycaemic control between the various drugs, sulfonylureas and repaglinide were associated with greater risk for ... 6minutes REGIONAL NEWS: MICROSOFT HIRES FORMER STAPLES … - Jan 23, 2008 1997 ; 700+ words ... ... the Food and Drug Administration recommended yesterday that Novo Nordisk's repaglinide be approved to treat Type II diabetes. ... Pay-Per-View - Seattle Post-Intelligencer - HighBeam Research Article: DRUG CAPSULE; WHAT YOU SHOULD KNOW - The Milwaukee … - Jan 9, 2006 Prandin (repaglinide) What it does: Prandin is an oral agent used to treat type 2 diabetes. It's in a class of drugs k... Pay-Per-View - Milwaukee Journal Sentinel - HighBeam Research Medication as last resort | Article from New Straits Times | HighBeam... - Nov 26, 2006 Examples of drugs in this class are repaglinide and nateglinide. (The report on possible effectiveness of the latter for the prevention of diabetes and ... Pay-Per-View - New Straits Times - HighBeam Research Novo slÃ¥r igen i patentstrid - Aug 14, 2007 ...en ANDA-ansøgning, en ansøgning om godkendelse af generisk medicin, til de amerikanske sundhedsmyndigheder FDA, der dækkede det aktive stof Repaglinide. ... Børsen Online Postprandial Hyperglycemia - Jun 13, 2006 Repaglinide (Prandin) and nateglinide (Starlix) stimulate the pancreas to release insulin in a glucose-dependent fashion. (That is, the more glucose there ... Diabetes Self Management Step 8: Drugs and insulin - May 1, 2006 Examples are glyburide, glipizide, glimepiride and repaglinide. These drugs:. Most people want to avoid taking insulin to control their diabetes. ... Waco Tribune-Herald - Waco Tribune Herald Comparison of Top 10 Diabetes Drugs Finds Older is Better - Jul 25, 2007 In addition to metformin, the thiazolidinediones and sulfonylureas, drugs included in their analysis were repaglinide (Prandin), miglitol (Glyset), ... SeniorJournal.com Sulfonylureas :: Diabetes Self-Management - Jun 16, 2006 Repaglinide (Prandin), a member of another class of beta-cell stimulating drugs called meglitinides, acts in response to rises in blood glucose levels ... Diabetes Self Management Study: Older Diabetes Drugs Safe to Use - Jul 18, 2007 ..._Glimepiride, glipizide, glyburide and repaglinide lead to too-low blood sugar more often than other drugs do. _Metformin and acarbose more often cause ... go.com Torrent Signs agreement with Tasly to market Cardio-tonic Pill - Oct 11, 2006 The Company was the first to launch global blockbusters like Atenolol, Rosiglitazone and Repaglinide in India and enjoys market leadership in many brands in ... Equity Bulls Oral Medicines for Type 2 Diabetes - Jul 18, 2006 Taking a missed dose of repaglinide or nateglinide between meals could result in hypoglycemia because these drugs stimulate the release of insulin from the ... Diabetes Self Management Diabetes in later life. - Jan 19, 2006 Insulin secretagogues These agents include sulphonylureas and the rapid-acting insulin secretagogues repaglinide and nataglinide. ... Free with registration - Update - AccessMyLibrary.com Independent Nurse: Clinical - Prescribing - Oral therapy options for... - Sep 30, 2005 Nateglinide and repaglinide are post-prandial glucose regulators (PPGRs).(8) They act by stimulating first-phase insulin secretion, which occurs immediately ... Free with registration - GP - AccessMyLibrary.com Treatments and devices for future diabetes management. - May 3, 2005 The two approved for use in the UK are repaglinide, which is indicated for use as monotherapy, and nateglinide, which is indicated for use in oral ... Nursing Times Older Is Better: Top Ten Comparison Of Diabetes Drugs Give Metformin ... - Jul 29, 2007 In addition to metformin, the thiazolidinediones and sulfonylureas, drugs included in their analysis were repaglinide (Prandin), miglitol (Glyset), ... sciencedaily.com Insulin Resistance - May 17, 2006 ...glipizide (Glucotrol, Glucotrol XL), glimepiride (Amaryl), and repaglinide (Prandin), lower blood glucose levels by boosting insulin secretion. ... Diabetes Self Management New diabetic drug class shows promise - Mar 24, 2005 There are only two commercially available meglitinides: NovoNordisk's Repaglinide (Prandin) and Novartis' Nateglinide (Starlix). ... DrugResearcher.com ADA type 2 diabetes goals still not being met.(Metabolic Disorders)( … - Jul 15, 2005 ...and 16% nonsulfonylurea secretagogues (8% repaglinide and 8% nateglinide). Of these, monotherapy was used in 25%, two glucose-lowering drugs in 41%, ... Free with registration - Family Practice News - AccessMyLibrary.com Glimepiride in the medical management of Type 2 diabetes - Oct 23, 2005 ...thiazolidinediones (pioglitazone and rosiglitazone), meglitinide analogues (repaglinide), amino acid D-phenylalanine derivatives (nateglinide), ... MedIndia Biocon to launch MAb in SEA markets - Feb 22, 2007 ...nateglinide, a novel drug designed to prevent postprandial hyperglycemia, pioglitazone for type II diabetes to repaglinide, a fast-acting, short-acting ... pharmabiz.com The American Heart Association now recommends that patients should … - Jul 15, 2006 Meglitinides (repaglinide, nateglinide). Stimulate insulin secretion. These newer drugs are better than sulfonylureas in controlling glucose spikes after ... HealthCentral.com Oral Medicines for Type 2 Diabetes - Jul 18, 2006 There is one meglitinide on the market, repaglinide (Prandin), and one d-phenylalanine derivative, nateglinide (Starlix). These drugs are not sulfonylureas, ... Diabetes Self Management Diabex XR - Metformine hydrochloride - Medical Drug - Oct 4, 2008 These include other classes of antihyperglycaemic agents such as sulfonylureas and repaglinide, anti-hypertensive drugs such as beta-blockers, ... Virtual Medical Centre - The Virtual Medical Centre Oral Agent Combination Therapy - Jun 14, 2005 ...nateglinide or repaglinide -- in variable dose based on meal size and exercise in a manner similar to that used with variable prandial insulin dosing. ... Medscape PulseClinical: Need to know Diabetes. - Nov 16, 2006 There is a niche market for the insulin secretagogues repaglinide and nateglinide. Their rapid action may be of value in people with high postprandial peaks ... Free with registration - Pulse - AccessMyLibrary.com What Is the Role of Rosiglitazone in Steroid-Induced Diabetes? - Mar 8, 2007 If postprandial hyperglycemia is the predominant concern, a short-acting insulin secretagogue (eg, nateglinide or repaglinide) may be sufficient. ... Medscape Medications scheduled to come off patent in 2007 *.(Drug and Formulary... - Feb 1, 2007 Perindopril Aceon Not available Repaglinide Prandin Not available Ropinirole Requip Not available Sibutramine Mericlia Not available Sumatriptan Imitrex ... Free with registration - Formulary - AccessMyLibrary.com A New Face in The Crowd: FGF-21 - Jun 21, 2005 Sulfonylurea drugs like glyburide and glipizide are examples of the former category, as are newer agents like repaglinide (Prandinâ„¢) and nateglinide ... Diabetes In Control UM study: Economic rebound starts next year - Aug 20, 2007 Laboratories Ltd. announced on Monday that the US Food and Drug Administration granted it tentative approval of a new drug application for Repaglinide, ... Crain's Detroit Business FDA panel recommends expanded diabetes drug testing - Jul 10, 2008 A regimen in which there was more use of repaglinide, rosiglitazone, insulin and/or alpha glucosidase inhibitor showed increased mortality risk in the ... Endocrine Today Diabetes mellitus drugs in India - Nov 21, 2007 There are two molecules available in this group ie Repaglinide and Nateglinide. These drugs are absorbed more rapidly and attained its peak plasma level ... pharmabiz.com Type-2 diabetes 'better treated' by cheap drugs.(Brief article) - Jul 20, 2007 HbA1c was lowered by around 1 percentage point by metformin, sulphonylureas, thiazolidinediones and repaglinide. A slightly weaker effect on glycaemic ... Free with registration - GP - AccessMyLibrary.com Brand Names/Synonyms: Repaglinide is also known by the following brand names and/or synonymsAG-EE 388 ZW; AG-EE 623 ZW; Prandin; Repaglinida [Inn-Spanish]; Repaglinide; Repaglinide [Usan]; Repaglinidum [Inn-Latin] Drug Category: Repaglinide is categorized under the following by the FDA: Hypoglycemic Agents; Meglitinides; ATC:A10BX02 Dosage Forms: TABLET Absorption: Rapid (bioavailability is 56%) Interactions: [an error occurred while processing this directive] Chemical IUPAC Name: 2-ethoxy-4-[[3-methyl-1-[2-(1-piperidyl)phenyl]-butyl]carbamoylmethyl]benzoicacid |
|
Health Home | Conditions | Cancer | Medications | Surgery | Vaccines The Cancer News Network
COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy |
